Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 126 Breast Neoplasms 78 Neoplasms 48 Prostatic Neoplasms 19 Fatigue 16 Obesity 14 Colorectal Neoplasms 13 Lung Neoplasms 11 Polycystic Ovary Syndrome 10 Colonic Neoplasms 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Head and Neck Neoplasms 7 Weight Loss 6 Ovarian Neoplasms 6 Rectal Neoplasms 5 Multiple Myeloma 5 Lymphedema 5 Leukemia 5 Inflammation 5 Pancreatic Neoplasms 4 Overweight 4 Multiple Endocrine Neoplasia Type 1 4 Lymphoma 4 Leukemia, Myeloid, Acute 4 Insulin Resistance 4 Depression 4 Cognitive Dysfunction 4 Brain Neoplasms 4 Stomach Neoplasms 3 Peripheral Nervous System Diseases 3

Interventions

Sildenafil Citrate 2 udenafil 1 methyl 3-mercaptopropionimidate 1 bicalutamide 1 alpha-Tocopherol 1 Vitamin E 1 Tamoxifen 1 Tadalafil 1 Tacrolimus 1 Restraint, Physical 1 Psychiatric Rehabilitation 1 Preservation, Biological 1 Pentoxifylline 1 Menogaril 1 Long-Term Synaptic Depression 1 Intraoperative Neurophysiological Monitoring 1 GPI 1485 1 Exercise 1 Erythropoietin 1 Early Intervention, Educational 1 Dutasteride 1 Cell- and Tissue-Based Therapy 1 Atorvastatin 1 Arginine 1 ArginMax 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Erectile Dysfunction × Exercise × Clear all

NCT00873665 2013-10-28

Erectile Dysfunction Study

Duke University

Phase NA Completed

Erectile Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡